AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis
AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis - read this article along with other careers information, tips and advice on BioSpace
France General Neuroimmunol Neuroinflamm Patrick Vermersch French Agency University Of Lille Drug Administration
Source: biospace.com